Limitations included the absence of tumour size and grade, which were excluded due to a high percentage of missing data, the lack of Ki67 data, quality of life metrics, and the unavailability of information on patient symptoms and co-morbidities in primary care, as these are not reported in NCRAS. Here, MKI67 is linked to neoplasm.